A kidney transplant depends on various situations and conditions such as kidney failure caused due to various reasons (kidney trauma, severe dehydration). As a human can live on one kidney for years, it is not a preferred procedure in many countries. Moreover, unaffordability is another reason for not undergoing a kidney transplant procedure in underdeveloped countries.
Availability of a donor is one of the major factors impacting the procedure numbers for kidney transplant.
The global kidney transplant market is estimated to be valued at US$ 81,037 Mn in 2021 and is expected to register a CAGR of 3.1% and reach US$ 1,06,179 Mn by 2028.
Figure 1. Global Kidney Transplant Market (US$ Mn), By Type, 2021
Figure 1.1. Global Kidney Transplant Market (US$ Mn), By Type, 2028
Kidney Transplant Market Report Coverage
|Base Year:||2020||Market Size in 2021:||US$ 81,037 Mn|
|Historical Data for:||2017 to 2020||Forecast Period:||2021 to 2028|
|Forecast Period 2021 to 2028 CAGR:||3.1%||2028 Value Projection:||US$ 106,179 Mn|
Sanofi, Pfizer, Inc., Novartis AG., B. Braun Melsungen AG, Fresenius Medical Care, Medtronic, Preservation Solution Inc., TransMedics, Inc., Organ Recovery Systems, and Transonic Systems Inc.
|Restraints & Challenges:||
Figure 2. Global Kidney Transplant Market (US$ Mn), By Region, 2021
Figure 2.1. Global Kidney Transplant Market (US$ Mn), By Region, 2028
For instance, according to an article published in Karger Journals in 2017, stated that in the U.S. acute kidney injury is associated with an increase in hospitalization costs.
Global Kidney Transplant Market – Impact of Coronavirus (Covid-19) Pandemic
The coronavirus (COVID-19) pandemic is the most recent outbreak, which was first reported on December 31, 2019, in Wuhan, China. The shutdown disrupted the supply, distribution, and manufacturing of medical supplies globally. Moreover, due to social distancing, the footfall in clinics and health institutions has fallen by more than 70% during this pandemic, which has led to decrease in the number of surgical procedures, clinical trials, research and development activities and others, which has negatively impacted the market growth.
However, the COVID-19 pandemic has increased the demand for PPE kits and gloves, which has led to increase in production of PPE kits, thereby, assisting the market growth.
Organ procurement rates declines as per the kidney transplantation rates decline. About 39% decrease in referrals of organs was reported by the U.K. as compared to previous year, 2020, France reported 16% of decrease in all deceased organs. Procurement challenges faced by transplant programs and organizations were part of these declines such as, insufficient testing capacity and delayed COVID-19 test results, restricted operating room availabilities, and mandates for the avoidance of nonessential clinical activities to preserve personnel and protective equipment.
Global Kidney Transplant Market - Restraint
As per stated in Penn Medicine News, shortage of kidneys continues to be a public health crisis in the U.S. About 20,000 transplants are performed per year and more than 90,000 individuals are waiting for kidney transplants. Moreover, 5,000 people die waiting and without getting a transplant.
For instance, according to Journal of the American Society of Nephrology, the researchers found that 493 of kidneys could be matched in terms of biopsy-evaluated quality and other donor characteristics, to 493 kidneys that were transplanted in France, where transplant practice is not much restricted. As per the study of researchers, the survival rate of these 493 kidneys is 93% at one year, 83% at five years, and 68% at 10 years, as many kidneys with donor in the U.S. are discarded nonessentially.
Major players operating in the global kidney transplant market include Sanofi, Pfizer, Inc., Novartis AG., B. Braun Melsungen AG, Fresenius Medical Care, Medtronic, Preservation Solution Inc., TransMedics, Inc., Organ Recovery Systems, and Transonic Systems Inc.
Frequently Asked Questions